Evaluation of Patients Treated with Lipo-prostaglandin E 1 for Chronic Severe Type B Hepatitis by MELD Prognosis Analysis
- VernacularTitle:应用MELD预后分析评价前列腺素E_1脂微球载体制剂治疗慢性乙型重型肝炎的疗效
- Author:
Chusheng ZHAO
;
Shaorui LIN
;
Genglong GUO
- Publication Type:Journal Article
- Keywords:
Chronic severe hepatitis;
Lipo PGE 1;
Model for end-stage live disease;
Therapeutic effect
- From:
China Pharmacy
2001;0(09):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the therapeutic effect of Lipo-prostaglandin E 1 (Lipo PGE 1 )on chronic severe type B hepatitis by MELD(Model for end-stage live disease)prognosis analysis.METHODS:Of a total of115cases with chronic severe type B hepatitis,57were randomly assigned to receive a common combined therapy and58to receive a common combined therapy plus Lipo PGE 1 for4weeks,the MELD score and prognosis of diseases of the2groups were assessed.RE-SULTS:The MELD score in the treatment group(20.12?8.97)was lower than that of the control group(24.76?10.41)after4weeks’treatment(P
